Adverse Events in Multimodal Treatment Therapies for High-Grade Gliomas

被引：0

作者：

Ngwenya, Laura B. ^{[1
]}

Chiocca, E. Antonio ^{[1
]}

机构：

[1] Ohio State Univ, Med Ctr, Dept Neurol Surg, Columbus, OH 43210 USA

来源：

WORLD NEUROSURGERY | 2011年 / 76卷 / 1-2期

关键词：

BCNU wafers; Hydrocephalus; Safety; Ventricular wall defect; ADJUVANT TEMOZOLOMIDE; CARMUSTINE IMPLANTS; MALIGNANT GLIOMA; BCNU WAFERS; GLIOBLASTOMA; RADIOTHERAPY; CONCOMITANT;

D O I：

10.1016/j.wneu.2010.11.018

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：67 / 68

页数：2

共 9 条

[1]

[Anonymous], 2010, GLIAD WAF PRESCR INF

[2] First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience [J].

Bock, Hans Christoph ;

Puchner, Maximilian Josef Anton ;

Lohmann, Frauke ;

Schuetze, Michael ;

Koll, Simone ;

Ketter, Ralf ;

Buchalla, Ruediger ;

Rainov, Nikolai ;

Kantelhardt, Sven R. ;

Rohde, Veit ;

Giese, Alf .

NEUROSURGICAL REVIEW, 2010, 33 (04) :441-449

[3]

DELLAPUPPA A, 2010, WORLD NEURO IN PRESS

[4] Fatal outcome related to carmustine implants in glioblastoma multiforme [J].

Gallego, J. M. ;

Barcia, J. A. ;

Barcia-Marino, C. .

ACTA NEUROCHIRURGICA, 2007, 149 (03) :261-265

[5]

GIESE A, 2010, CEN EUR NEUROSURG

[6] A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients [J].

Pan, Edward ;

Mitchell, Susan B. ;

Tsai, Jerry S. .

JOURNAL OF NEURO-ONCOLOGY, 2008, 88 (03) :353-357

[7]

Perry J, 2007, Curr Oncol, V14, P189, DOI 10.3747/co.2007.147

[8] Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma [J].

Stupp, R ;

Mason, WP ;

van den Bent, MJ ;

Weller, M ;

Fisher, B ;

Taphoorn, MJB ;

Belanger, K ;

Brandes, AA ;

Marosi, C ;

Bogdahn, U ;

Curschmann, J ;

Janzer, RC ;

Ludwin, SK ;

Gorlia, T ;

Allgeier, A ;

Lacombe, D ;

Cairncross, JG ;

Eisenhauer, E ;

Mirimanoff, RO ;

Van Den Weyngaert, D ;

Kaendler, S ;

Krauseneck, P ;

Vinolas, N ;

Villa, S ;

Wurm, RE ;

Maillot, MHB ;

Spagnolli, F ;

Kantor, G ;

Malhaire, JP ;

Renard, L ;

De Witte, O ;

Scandolaro, L ;

Vecht, CJ ;

Maingon, P ;

Lutterbach, J ;

Kobierska, A ;

Bolla, M ;

Souchon, R ;

Mitine, C ;

Tzuk-Shina, T ;

Kuten, A ;

Haferkamp, G ;

de Greve, J ;

Priou, F ;

Menten, J ;

Rutten, I ;

Clavere, P ;

Malmstrom, A ;

Jancar, B ;

Newlands, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (10) :987-996

[9] A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma [J].

Westphal, M ;

Hilt, DC ;

Bortey, E ;

Delavault, P ;

Olivares, R ;

Warnke, PC ;

Whittle, IR ;

Jääskeläinen, J ;

Ram, Z .

NEURO-ONCOLOGY, 2003, 5 (02) :79-88

← 1 →